Novak Djokovic holds major stake in firm developing Covid drug

Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment, the Danish company’s CEO said Wednesday. “He is one of the founders of my company we founded in June 2020,” the chief executive of QuantBioRes, Ivan Loncarevic, … Read more

Pfizer begins application for Canada’s approval of Covid-19 pill

Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada’s approval of its oral COVID-19 antiviral drug candidate. The pill, PF-07321332, is designed to block a key enzyme needed for the coronavirus to multiply. The move comes after the Canadian government announced on Tuesday that it was in … Read more

Pharmaceutical firms turn focus to inhalation products for Covid-19

After injectables and oral solid drugs, now pharmaceutical firms are focusing on coming up with re-purposed inhalation products for Covid-19. While drug major Lupin is working on a remdesivir powder for inhalation, Mumbai-based Glenmark has tied up with a Canadian Biotech firm for Nitric Oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission. … Read more

Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months

After receiving the patent for a particular molecule, according to a senior official. Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. “We … Read more